Repatriation Medical Authority - Notice of Investigation - acute myeloid leukaemia - focussed

Overview

The Repatriation Medical Authority (the Authority), under the Veterans' Entitlements Act 1986, has announced its intention to conduct an investigation into the potential link between insecticides and acute myeloid leukaemia. This investigation stems from the need to address gaps in the understanding of factors contributing to this form of leukaemia, particularly in the context of veterans. The Authority's initiative aligns with the legislative framework established by the Parliament of Australia to ensure comprehensive support and medical assessment for veterans' health issues. The primary objective of this investigation is to gather and evaluate relevant data to inform future policy and medical guidance, thereby potentially enhancing the entitlements and health outcomes for affected veterans. The Authority invites submissions from a range of stakeholders, including individuals eligible for veterans' benefits, representatives of veterans' organisations, and experts in relevant fields. These submissions are crucial for providing diverse perspectives and expertise that will inform the investigation. Submissions must be submitted by 19 November 2019, and can be lodged electronically through the RMA website, via email, or by post. The Authority's first meeting to discuss this investigation is scheduled for 3 December 2019, marking the beginning of a structured approach to uncovering the potential connections between insecticides and acute myeloid leukaemia among veterans.

Scope and Application

The Repatriation Medical Authority, pursuant to section 196G of the Veterans' Entitlements Act 1986, has announced its intention to conduct an investigation into the potential link between insecticides and acute myeloid leukaemia. This investigation will be contextualised by Statements of Principles Instrument Nos. 71 & 72 of 2015. The Authority's notice invites submissions from a range of stakeholders, including individuals eligible for pensions or compensation under the VEA or the Military Rehabilitation and Compensation Act 2004, organisations representing veterans and their dependants, the Repatriation Commission or the Military Rehabilitation and Compensation Commission, and experts with relevant field knowledge. The aim is to gather comprehensive insights into the matter from those directly affected or knowledgeable in pertinent areas. Submissions can be made electronically via the RMA website, by email, or by post, with all written submissions due no later than 19 November 2019. The scope of the investigation under the VEA extends to any persons or entities that have a direct interest or expertise relevant to the issue of insecticides as a factor in acute myeloid leukaemia. The geographic and jurisdictional reach of this investigation is nationwide, impacting veterans across Australia who may be affected by the findings. The Authority's notice does not explicitly mention any exclusions or exemptions, suggesting that all relevant parties are encouraged to contribute to the investigation. While the primary legislation is the Veterans' Entitlements Act 1986, the involvement of the Military Rehabilitation and Compensation Act 2004 indicates a broad application across both pension and compensation frameworks for veterans.

Key Provisions

Section 196G of the Veterans' Entitlements Act 1986 (VEA) provides that the Repatriation Medical Authority (the Authority) intends to investigate the role of insecticides as a factor in acute myeloid leukaemia. This investigation is specifically linked to Statements of Principles Instrument Nos. 71 and 72 of 2015. The Authority is inviting submissions from various stakeholders, including those eligible to claim pensions or compensation under the VEA or Military Rehabilitation and Compensation Act 2004 (MRCA), organisations representing veterans or their dependents, and experts in relevant fields. These submissions must be made in writing and received by 19 November 2019. The Authority will hold its first meeting on 3 December 2019 to discuss the investigation. Submissions can be lodged electronically via the RMA website, emailed, or posted, with guidelines and further assistance available from the RMA Secretariat. The Act imposes several obligations on the parties it governs. For instance, those eligible to make claims under the VEA or MRCA, as well as organisations representing veterans and their dependents, are required to submit written submissions to the Authority by the specified deadline. Additionally, individuals with expertise in relevant fields are invited to contribute their insights. The Authority, in turn, has the responsibility to organise and conduct the investigation, ensuring that all relevant submissions are considered. The Authority must also make necessary arrangements to hold the first meeting to discuss the investigation, which is set for 3 December 2019. Furthermore, the Authority is responsible for providing guidelines and assistance to facilitate the submission process. Breach of the obligations set out in the Act may lead to various consequences. While the Act does not explicitly outline specific offences, failure to meet the submission deadlines or neglect of the obligations could result in civil or administrative penalties. For instance, not submitting the required information by the deadline may lead to the exclusion of certain evidence or viewpoints from the investigation, potentially impacting the outcomes. Additionally, if the Authority fails to conduct the investigation as per the legislative requirements, it may face legal challenges or sanctions. The precise nature and extent of penalties are not detailed in the Act, but they could include financial penalties, corrective actions, or other measures deemed appropriate by the relevant authorities.